ArticleNature communications2022

Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression.

Andrea Comba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.